VETACAINE INJECTION

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

Buy It Now

Active ingredient:
MEPIVACAINE HYDROCHLORIDE
Available from:
TROY LABORATORIES PTY LTD
INN (International Name):
mepivacaine HCl(20mg/mL)
Pharmaceutical form:
PARENTERAL LIQUID/SOLUTION/SUSPENSION
Composition:
MEPIVACAINE HYDROCHLORIDE CAINE Active 20.0 mg/ml
Units in package:
100mL
Class:
VM - Veterinary Medicine
Manufactured by:
TROY LABORATORIES
Therapeutic group:
HORSE | COLT | DONKEY | ENDURANCE HORSE | FILLY | FOAL | GELDING | HIGH PERFORMANCE HORSES | HORSES AT STUD | MARE | PACER | POL
Therapeutic area:
ANAESTHETICS/ANALGESICS
Therapeutic indications:
ANAESTHETIC - LOCAL/GENERAL | GENERAL ANAESTHETIC | IMMOBILISER | LOCAL ANAESTHETIC | PREMEDICATION | SEDATIVE | TRANQUILLISER | TRAVEL SICKNESS
Product summary:
Poison schedule: 4; Withholding period: WHP: Meat: Nil; Host/pest details: HORSE: [ANAESTHETIC - LOCAL/GENERAL]; Poison schedule: 4; Withholding period: ; Host/pest details: HORSE: [ANAESTHETIC - LOCAL/GENERAL]; Local anaesthetic for use in horses.
Authorization status:
Registered
Authorization number:
51902
Authorization date:
2020-07-01

Main panel

-

c o n t a i n e r

PRESCRIPTION ANIMAL REMEDY

KEEP

OUT

OF

REACH

OF

CHILDREN

FOR

ANIMAL

TREATMENT

ONLY

VETACAINE INJECTION

ACTIVE CONSTITUENT:

20mg/mL MEPIVACAINE HYDROCHLORIDE

Local anaesthetic for use in horses

A n c i l l a r y

p a n e l

ILIUM

OOmL

- DIRECTIONS FOR USE:

FOR NERVE BLOCK (lameness, pain relief in osteoarthritis): 3 to 15

FOR

EPIDURAL

ANAESTHESIA (animal standing): 5 to 20mL

FOR INTRAARTICULAR ANAESTHESIA (removal of fracture chips, arthritis):

IO to 15mL.

FOR INFILTRATION: As required

MEAT WITHHOLDING PERIOD: NIL

TROY LABORATORIES PTY. LIMITED

98 LONG ST. SMITHFIELD, NSW 2164 AUSTRALIA

Dispose

empty

container

wrapping

with

paper

putting

garbage.

Protect from light. Store below

30°C

(Room Temperature).

. .

NRA Approval

B a t c h : .

Expiry:

1 of2

Draft

label

-

5

May

1999

M a i n p a n e l

-

c a r t o n

PRESCRIPTION ANIMAL REMEDY

KEEP

OUT

OF

REACH

OF

CHILDREN

FOR ANIMAL TREATMENT ONLY

VETACAINE INJECTION

ACTIVE CONSTITUENT:

20mg/mL MEPIVACAINE HYDROCHLORIDE

Local anaesthetic for use in hors&

A n c i l l a r y

P a n e l

1

ILIUM

OOmL

DIRECTIONS

FOR

USE:

e

FOR NERVE BLOCK (lameness, pain relief in osteoarthritis): 3 to 15

FOR

EPIDURAL

ANAESTHESIA (animal standing): 5 to 20mL

FOR INTRAARTICULAR ANAESTHESIA (removal of fracture chips, arthritis):

15mL.

FOR INFILTRATION: As required

MEAT WITHHOLDING PERIOD: NIL

Anciiila’ry

P a n e l

2

TROY LABORATORIES PTY. LIMITED

98 LONG ST. SMITHFIELD, NSW 2164 AUSTRALIA

Dispose

empty

container

wrapping

with

paper

putting

garbage.

Protect from light. Store below

30°C

(Room Temperature).

Approval

Batch:.

Expiry:

2of2

D r a f t

l a b e l

-

5

M a y

1 9 9 9

MATERIAL SAFETY DATA SHEET

Product Name: Vetacaine Injection

Page: 1 of 4

This revision issued: July, 2010

MATERIAL SAFETY DATA SHEET

Issued by: Troy Laboratories Australia Pty Ltd

Phone: 02 9677 9000

Poisons Information Centre: 13 1126 from anywhere in Australia, (0800 764 766 in New Zealand)

Section 1 - Identification of The Material and Supplier

Troy Laboratories Australia Pty. Ltd

ABN: 21 000 283 769

Tel:

(02)9677 9000

31-35 Glendenning Road

Fax:

(02) 9677 9300

Glendenning NSW 2761

Chemical nature:

Mepivacaine hydrochloride is a cocaine derivative - presented as the hydrochloride

salt for increased solubility and faster action.

Trade Name:

Vetacaine Injection

Product Code:

3818

Product Use:

Local anaesthetic for use in horses.

Creation Date:

August, 2005

This version issued:

July, 2010

and is valid for 5 years from this date.

Section 2 - Hazards Identification

Statement of Hazardous Nature

This product is classified as:

Not classified as hazardous according to the criteria of SWA Australia.

Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code.

Risk Phrases:

Not Hazardous - No criteria found.

Safety Phrases:

S25, S45. Avoid contact with eyes. In case of accident or if you feel unwell, contact a doctor or

Poisons Information Centre immediately (show the label where possible).

SUSDP Classification:

ADG Classification:

None allocated. Not a Dangerous Good under the ADG Code.

UN Number:

None allocated

Emergency Overview

Physical Description & Colour

: Clear, colourless liquid.

Odour:

No odour.

Major Health Hazards:

no significant risk factors have been found for this product.

Potential Health Effects

Adverse reactions to mepivacaine include nervousness, dizziness, tinnitus (ringing in ears) blurred vision, tremor,

drowsiness, numbness, disorientation, nausea and vomiting. Convulsions, unconsciousness, low blood pressure,

respiratory depression and slowed heart beat may occur in cases of severe toxicity or in persons allergic to

mepivacaine.

This is a pharmacologically active preparation, and contact should be avoided except in actual use. If you have come

into contact with this product, seek medical attention if you feel drowsy or experience any unusual symptoms such as

those listed above.

Inhalation

Short Term Exposure:

Significant inhalation exposure is considered to be unlikely. Available data indicates that

this product is not harmful. However product may be mildly irritating, although unlikely to cause anything more than

mild transient discomfort.

Long Term Exposure:

No data for health effects associated with long term inhalation.

Skin Contact:

Short Term Exposure:

Available data indicates that this product is not harmful. It should present no hazards in

normal use. However product is believed to be mildly irritating, and cause transient numbness to skin but is unlikely to

cause anything more than mild transient discomfort.

Long Term Exposure:

No data for health effects associated with long term skin exposure.

Eye Contact:

Short Term Exposure

: Exposure via eyes is considered to be unlikely. This product is believed to be mildly

irritating, and will cause numbness to eyes but is unlikely to cause anything more than mild transient discomfort.

Long Term Exposure

: No data for health effects associated with long term eye exposure.

Product Name: Vetacaine Injection

Page: 2 of 4

This revision issued: July, 2010

MATERIAL SAFETY DATA SHEET

Issued by: Troy Laboratories Australia Pty Ltd

Phone: 02 9677 9000

Poisons Information Centre: 13 1126 from anywhere in Australia, (0800 764 766 in New Zealand)

Ingestion:

Short Term Exposure

: Significant oral exposure is considered to be unlikely. However, this product is believed to

be mildly irritating to mucous membranes but is unlikely to cause anything more than mild transient discomfort.

Numbness of gums, tongue and other tissues is likely.

Long Term Exposure

: No data for health effects associated with long term ingestion.

Carcinogen Status:

SWA:

No significant ingredient is classified as carcinogenic by SWA.

NTP:

No significant ingredient is classified as carcinogenic by NTP.

IARC:

No significant ingredient is classified as carcinogenic by IARC.

Section 3 - Composition/Information on Ingredients

Ingredients

CAS No

Conc,%

TWA (mg/m

3

)

STEL (mg/m

3

)

Mepivacaine hydrochloride

1722-62-9

not set

not set

Other non hazardous ingredients

secret

<10

not set

not set

Water

7732-18-5

to 100

not set

not set

This is a commercial product whose exact ratio of components may vary slightly. Minor quantities of other non

hazardous ingredients are also possible.

The TWA exposure value is the average airborne concentration of a particular substance when calculated over a normal 8 hour working day for a 5

day working week. The STEL (Short Term Exposure Limit) is an exposure value that should not be exceeded for more than 15 minutes and should

not be repeated for more than 4 times per day. There should be at least 60 minutes between successive exposures at the STEL. The term "peak "is

used when the TWA limit, because of the rapid action of the substance, should never be exceeded, even briefly.

Section 4 - First Aid Measures

General Information:

You should call The Poisons Information Centre if you feel that you may have been poisoned, burned or irritated by

this product. The number is 13 1126 from anywhere in Australia (0800 764 766 in New Zealand) and is available at all

times. Have this MSDS with you when you call.

Self Injection: Accidental self injection may lead to an inflammatory response. Medical advice should be sought on

the management of deep injections, particularly those near a joint or associated with bruising. If possible the

application of gentle squeezing pressure with absorbent material (e.g. facial tissues) at the injection site will swab up

unabsorbed vaccine. Strong squeezing of the site should be avoided. The damaged area should be thoroughly

cleansed and a topical antiseptic applied.

Inhalation:

No first aid measures normally required. However, if inhalation has occurred, and irritation has

developed, remove to fresh air and observe until recovered. If irritation becomes painful or persists more than about

30 minutes, seek medical advice.

Skin Contact:

Wash gently and thoroughly with water (use non-abrasive soap if necessary) for 10 minutes or until

chemical is removed. If irritation persists, repeat flushing and obtain medical advice.

Eye Contact:

Immediately flush the contaminated eye(s) with lukewarm, gently flowing water for 5 minutes or until

the product is removed, while holding the eyelid(s) open. Obtain medical advice immediately if irritation occurs.

Ingestion:

If product is swallowed or gets in mouth, wash mouth with water and give some water to drink. If

symptoms develop, or if in doubt contact a Poisons Information Centre or a doctor.

Section 5 - Fire Fighting Measures

Fire and Explosion Hazards

: There is no risk of an explosion from this product under normal circumstances if it is

involved in a fire.

Only small quantities of decomposition products are expected from this products at temperatures normally achieved in

a fire. This will only occur after heating to dryness.

Fire decomposition products from this product are likely to be irritating if inhaled.

Extinguishing Media

: Not Combustible. Use extinguishing media suited to burning materials.

Fire Fighting

: If a significant quantity of this product is involved in a fire, call the fire brigade.

Flash point

:

Does not burn.

Upper Flammability Limit:

Does not burn.

Lower Flammability Limit:

Does not burn.

Autoignition temperature:

Not applicable - does not burn.

Flammability Class:

Does not burn.

Product Name: Vetacaine Injection

Page: 3 of 4

This revision issued: July, 2010

MATERIAL SAFETY DATA SHEET

Issued by: Troy Laboratories Australia Pty Ltd

Phone: 02 9677 9000

Poisons Information Centre: 13 1126 from anywhere in Australia, (0800 764 766 in New Zealand)

Section 6 - Accidental Release Measures

Accidental release

: This product is sold in small packages, and the accidental release from one of these is not

usually a cause for concern. For minor spills, refer to product label for specific instructions. No special protective

clothing is normally necessary because of this product. However it is good practice to wear latex gloves when

handling vaccines. In the event of a major spill, prevent spillage from entering drains or water courses and call

emergency services.

Section 7 - Handling and Storage

Handling

: Keep exposure to this product to a minimum, and minimise the quantities kept in work areas. Check

Section 8 of this MSDS for details of personal protective measures, and make sure that those measures are followed.

The measures detailed below under "Storage" should be followed during handling in order to minimise risks to

persons using the product in the workplace. Also, avoid contact or contamination of product with incompatible

materials listed in Section 10.

Storage

: This product is a Scheduled Poison. Observe all relevant regulations regarding sale, transport and storage

of this schedule of poison. Protect this product from light. Store in the closed original container in a dry, cool, well-

ventilated area out of direct sunlight. Make sure that the product does not come into contact with substances listed

under "Incompatibilities" in Section 10. Some liquid preparations settle or separate on standing and may require

stirring before use. Check packaging - there may be further storage instructions on the label.

Section 8 - Exposure Controls and Personal Protection

The following Australian Standards will provide general advice regarding safety clothing and equipment:

Respiratory equipment: AS/NZS 1715, Protective Gloves: AS 2161, Industrial Clothing: AS2919, Industrial Eye

Protection: AS1336 and AS/NZS 1337, Occupational Protective Footwear: AS/NZS2210.

SWA Exposure Limits

TWA (mg/m

3

)

STEL (mg/m

3

)

Exposure limits have not been established by SWA for any of the significant ingredients in this product.

No special equipment is usually needed when occasionally handling small quantities. The following instructions are

for bulk handling or where regular exposure in an occupational setting occurs without proper containment systems.

Ventilation:

No special ventilation requirements are normally necessary for this product. However make sure that

the work environment remains clean and that vapours and mists are minimised.

Eye Protection:

Eye protection such as protective glasses or goggles is recommended when product is being used.

Skin Protection:

You should avoid contact even with mild skin irritants. Therefore you should wear suitable

impervious elbow-length gloves and facial protection when handling this product. See below for material types.

Protective Material Types:

There is no specific recommendation for any particular protective material type.

Respirator:

Usually, no respirator is necessary when using this product. However, if you have any doubts consult

the Australian Standard mentioned above. Otherwise, not normally necessary.

Section 9 - Physical and Chemical Properties:

Physical Description & colour

Clear, colourless liquid.

Odour:

No odour.

Boiling Point:

Approximately 100°C at 100kPa.

Freezing/Melting Point:

Approximately 0°C.

Volatiles:

Water component.

Vapour Pressure:

2.37 kPa at 20°C (water vapour pressure).

Vapour Density:

No data.

Specific Gravity:

No data.

Water Solubility:

Completely soluble in water.

pH:

No data.

Volatility:

No data.

Odour Threshold:

No data.

Evaporation Rate:

No data.

Coeff Oil/water Distribution

No data

Autoignition temp:

Not applicable - does not burn.

Section 10 - Stability and Reactivity

Reactivity:

This product is unlikely to react or decompose under normal storage conditions. However, if you have

any doubts, contact the supplier for advice on shelf life properties.

Conditions to Avoid:

Store in the closed original container in a dry, cool, well-ventilated area out of direct sunlight.

Product Name: Vetacaine Injection

Page: 4 of 4

This revision issued: July, 2010

MATERIAL SAFETY DATA SHEET

Issued by: Troy Laboratories Australia Pty Ltd

Phone: 02 9677 9000

Poisons Information Centre: 13 1126 from anywhere in Australia, (0800 764 766 in New Zealand)

Incompatibilities:

strong acids, strong bases, strong oxidising agents.

Fire Decomposition:

Only small quantities of decomposition products are expected from this products at

temperatures normally achieved in a fire. This will only occur after heating to dryness. Carbon dioxide, and if

combustion is incomplete, carbon monoxide and smoke. Water. Carbon monoxide poisoning produces headache,

weakness, nausea, dizziness, confusion, dimness of vision, disturbance of judgment, and unconsciousness followed

by coma and death.

Polymerisation:

This product will not undergo polymerisation reactions.

Section 11 - Toxicological Information

Local Effects:

Target Organs:

none known

Classification of Hazardous Ingredients

Ingredient

Risk Phrases

No ingredient mentioned in the HSIS database is present in this product at hazardous concentrations.

Section 12 - Ecological Information

Insufficient data to be sure of status.

Section 13 - Disposal Considerations

Disposal:

Dispose of empty container by wrapping with paper and putting in garbage. Discarded needles should

immediately be placed in a designated and appropriately labelled sharps container.

Section 14 - Transport Information

ADG Code:

This product is not classified as a Dangerous Good. No special transport conditions are necessary

unless required by other regulations.

Section 15 - Regulatory Information

AICS:

All of the significant ingredients in this formulation are compliant with NICNAS regulations.

The following ingredients: Mepivacaine hydrochloride, are mentioned in the SUSDP.

Section 16 - Other Information

This MSDS contains only safety-related information. For other data see product literature.

Acronyms:

ADG Code

Australian Code for the Transport of Dangerous Goods by Road and Rail, 7th Edition

AICS

Australian Inventory of Chemical Substances

CAS Number

Chemical Abstracts Service Registry Number

IARC

International Agency for Research on Cancer

SWA

Safe Work Australia, formerly ASCC and NOHSC

NTP

National Toxicology Program (USA)

R-Phrase

Risk Phrase

SUSDP

Standard for the Uniform Scheduling of Drugs & Poisons

UN Number

United Nations Number

THIS MSDS SUMMARISES OUR BEST KNOWLEDGE OF THE HEALTH AND SAFETY HAZARD INFORMATION OF THE PRODUCT AND

HOW TO SAFELY HANDLE AND USE THE PRODUCT IN THE WORKPLACE. EACH USER MUST REVIEW THIS MSDS IN THE CONTEXT OF

HOW THE PRODUCT WILL BE HANDLED AND USED IN THE WORKPLACE.

IF CLARIFICATION OR FURTHER INFORMATION IS NEEDED TO ENSURE THAT AN APPROPRIATE RISK ASSESSMENT CAN BE MADE,

THE USER SHOULD CONTACT THIS COMPANY SO WE CAN ATTEMPT TO OBTAIN ADDITIONAL INFORMATION FROM OUR SUPPLIERS

OUR RESPONSIBILITY FOR PRODUCTS SOLD IS SUBJECT TO OUR STANDARD TERMS AND CONDITIONS, A COPY OF WHICH IS SENT

TO OUR CUSTOMERS AND IS ALSO AVAILABLE ON REQUEST.

Please read all labels carefully before using product.

This MSDS is prepared in accord with the SWA document “National Code of Practice for the Preparation of

Material Safety Data Sheets” 2nd Edition [NOHSC:2011(2003)]

Copyright © Kilford & Kilford Pty Ltd, July, 2010.

http://www.kilford.com.au/

Phone (02)9251 4532

Similar products

Search alerts related to this product

View documents history

Share this information